Could you elaborate on which treatments you think those are? I'm aware of monoclonal antibodies and other antiviral treatments, which are generally more difficult and expensive to distribute compared to vaccines, and are more susceptive to variant changes.

To reiterate: that doesn't mean that people shouldn't get antibody treatments, only that we should continue to practice "needs based" care: vaccinate everyone, and use the more drastic (expensive, logistically complex) treatments on those who need it the most.